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Abstract
Non-homologous end joining (NHEJ) is the major pathway for repair of DNA double-strand
breaks (DSBs) in human cells. NHEJ is also needed for V(D)J recombination and the development
of T and B cells in vertebrate immune systems, and acts in both the generation and prevention of
non-homologous chromosomal translocations, a hallmark of genomic instability and many human
cancers. X-ray crystal structures, cryo-electron microscopy envelopes, and small angle X-ray
scattering (SAXS) solution conformations and assemblies are defining most of the core protein
components for NHEJ: Ku70/Ku80 heterodimer; the DNA dependent protein kinase catalytic
subunit (DNA-PKcs); the structure-specific endonuclease Artemis along with polynucleotide
kinase/phosphatase (PNKP), aprataxin and PNKP related protein (APLF); the scaffolding proteins
XRCC4 and XLF (XRCC4-like factor); DNA polymerases, and DNA ligase IV (Lig IV). The
dynamic assembly of multi-protein NHEJ complexes at DSBs is regulated in part by protein
phosphorylation. The basic steps of NHEJ have been biochemically defined to require: 1) DSB
detection by the Ku heterodimer with subsequent DNA-PKcs tethering to form the DNA-PKcs-
Ku-DNA complex (termed DNA-PK), 2) lesion processing, and 3) DNA end ligation by Lig IV,
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which functions in complex with XRCC4 and XLF. The current integration of structures by
combined methods is resolving puzzles regarding the mechanisms, coordination and regulation of
these three basic steps. Overall, structural results suggest the NHEJ system forms a flexing
scaffold with the DNA-PKcs HEAT repeats acting as compressible macromolecular springs
suitable to store and release conformational energy to apply forces to regulate NHEJ complexes
and the DNA substrate for DNA end protection, processing, and ligation.
1. Introduction
Non-homologous end joining (NHEJ, sometimes referred to as classical, or C- NHEJ) is the
major pathway for repair of ionizing radiation (IR)-induced double-stranded DNA breaks
(DSBs) in human cells [1, 2]. NHEJ is required for antigen receptor gene rearrangements via
V(D)J recombination and the development of T and B cells in the vertebrate immune system
[3], and it is implicated in both the generation and prevention of non-homologous
chromosomal translocations, a major hallmark of genomic instability and many human
cancers [4]. The main proteins required for NHEJ are the Ku70/Ku80 heterodimer, the
catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs), the endo/structure
specific nuclease Artemis, the scaffolding protein XRCC4, DNA ligase IV (Lig IV) and
XRCC4-like factor, XLF. NHEJ can be thought of as occurring in three distinct stages: (1)
detection of the DSB by the Ku heterodimer, with subsequent tethering by DNA-PKcs to
form the DNA-PKcs-Ku-DNA complex (termed DNA-PK), (2) processing of IR-induced
lesions and (3) ligation of the DNA ends by Lig IV, that functions in complex with XRCC4
and XLF. DNA end processing is required to remove damaged DNA and non-ligatable end
groups at the termini of the DSB to facilitate ligation. End processing in response to IR-
induced damage may include a variety of enzymes including polynucleotide kinase/
phosphatase (PNKP), aprataxin and PNKP related protein (APLF), DNA polymerases and
Artemis [1, 5, 6] (Fig. 1).
Over the past few years it has become apparent that Ku plays multiple roles in NHEJ; not
only does it recognize DSB ends, it has catalytic activity [7, 8] and is required for
recruitment of multiple NHEJ proteins to the DSB (reviewed in [5, 6]). A picture is thus
emerging of the dynamic assembly of a multi-protein NHEJ complex at DSBs, the function
of which is regulated, at least in part, by protein phosphorylation [9]. Unraveling the
multiple protein-protein and protein-DNA interactions within such dynamic protein-DNA
assemblies presents formidable challenges for traditional approaches such as X-ray
crystallography; however, small angle X-ray scattering (SAXS) has emerged as a powerful
tool for elucidating overall shapes and conformations of protein-protein and protein-DNA
complexes [10, 11].
In addition, we are learning more about the pathway and cross-pathway interactions between
NHEJ and homologous recombination (HR) and its initiating complex MRE11-RAD50-
NBS1 (MRN) [12]. During S and G2 phases of the cell cycle when NHEJ and HR are both
active, the choice between which of the two pathways is used for repair is controlled in part
by resection of DSBs, as the 3′ single-strand DNA (ssDNA) generated by extensive
resection inhibits NHEJ but is required for Rad51 filament formation and strand invasion
during HR [13]. We can now start to consider the structural implications of the complexes
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acting in the two DSB repair pathways for mechanisms of pathway choice. Here, we will
review how structural biology on individual NHEJ components and, in some cases NHEJ
complexes, is providing important insights into the mechanism of NHEJ, how MRN
activities interface with NHEJ, and how this combined information may lead to
identification of critical interfaces that may be targets for therapeutic intervention.
2. The Ku70/80 heterodimer
The Ku70/80 heterodimer was initially described as an autoantigen in the blood of patients
with autoimmune disease [14]. Ku binds with high affinity to the ends of DSBs [15], targets
DNA-PKcs to DSB ends [16, 17] and plays critical roles in NHEJ (reviewed in [5, 6]). The
central DNA binding region of the heterodimer exists as a pre-formed ring that encircles
dsDNA [18], allowing Ku to not only bind double stranded (ds) DNA in a largely sequence
independent manner, but also to translocate away from the DSB end, allowing recruitment
of DNA-PKcs, which interacts directly with the DNA termini [19, 20]. The Ku heterodimer
is orientated such that Ku70 faces the DSB, whereas Ku80 is distal to the DSB [18, 20].
In addition to this central DNA binding core, Ku70 contains an acidic N-terminal region and
a C-terminal SAP (SAF-A/B, Acinus and PIAS) domain [21, 22]. The extreme N-terminal
region of Ku70 (the first 30 residues) contains twelve acidic amino acids (aspartic and
glutamic acids) and Ku70 is phosphorylated on serine 6 in vitro by DNA-PKcs [23] and in
vivo [24], providing additional negatively charged groups. The function of this region is
unknown but its acidic nature suggests possible interaction with basic histones, or possibly
DNA mimicry as proposed to involve such negative regions mimicking specific DNA
structures rather than standard dsDNA [25]. At the C-terminus of Ku70, the SAP domain
(residues 561–609) forms a well-defined helical structure that is linked to the DNA binding
core by a highly flexible linker (residues 536–560). Both the linker and the SAP domain are
reported to bind DNA in vitro [26, 27] suggesting that the SAP domain may assist in
tethering the Ku heterodimer to chromatin.
The C-terminal region (CTR) of Ku80 (residues 592–709) contains a globular domain
connected to the DNA binding core by a disordered, flexible linker [28, 29]. The CTR forms
a flexible arm that extents from the DNA binding core, suitable for interaction with other
proteins [30]. The extreme C-terminus of Ku80 contains twelve residues
(EGGDVDDLLDMI) shown to interact directly with DNA-PKcs [31, 32]. This region is
conserved in Ku80 from vertebrates but is not present in Arabidopsis thaliana,
Caenorhabditis elegans or Saccharomyces cerevisiae, consistent with the absence of DNA-
PKcs in these organisms [31, 33]. However, although cells lacking Ku80CTR are radiation
sensitive and have low DNA-PK activity [34], Ku80CTR was not absolutely required for
recruitment and activation of DNA-PKcs at DSBs [35]. Since DNA-PKcs only interacts with
full-length Ku heterodimer in the presence of DNA [36], it seems likely that the interaction
of DNA-PKcs and Ku on DNA is more complex, and involves more, than the extreme C
terminal 14 amino acids of Ku80. The core, DNA-binding region of the Ku heterodimer is
required for its interaction with XLF [37, 38] and residues L68, Y74 and I112 in the
vonWillebrand (vWA) domain of Ku80 are required for interaction with residues 182–184
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and 189 of APLF [39, 40]. Ku70 also interacts with XRCC4 but the region of interaction is
unknown [41].
3. DNA-PKcs
DNA-PKcs is a member of the phosphatidyl inositol 3-kinase (PIKK) family of serine/
threonine protein kinases [42]. Like the related protein kinases ataxia telangiectasia mutated
(ATM) and ATM, Rad3-related (ATR), it is composed of a large N-terminal α-helical
domain composed of multiple Huntington, Elongation factor 2, PP2A-A subunit, mTOR
(HEAT) repeats separated by a flexible linker to the C-terminal FRAP, ATM and TRRAP
(FAT) [43], kinase and FAT-C domains (Fig. 3). At over 4000 amino acids in length,
elucidation of the structure of DNA-PKcs represents a considerable challenge for structural
biology. Low resolution structures obtained from SAXS and cryo-electron microscopy (EM)
revealed the overall shape and dimensions of DNA-PKcs, including head and palm regions
separated by a large, central cavity with dimensions suitable for binding dsDNA [30, 44].
The presence of a smaller channel, possibly capable of binding single-stranded (ss) DNA,
was proposed to occur in the head region of DNA-PKcs [44], consistent with the ability of
DNA-PKcs to open or fray dsDNA ends [45]. The X-ray structure of DNA-PKcs (in
complex with the Ku80CTR) at 6.6 Å confirmed the overall shape and dimensions of DNA-
PKcs and revealed that the FAT, kinase and FATC domains are located in the head/crown of
the molecule while the N-terminal HEAT repeat region forms the sides or arms of the
molecule, which surround the central cavity [46]. Of note, a gap was detected at the base of
the arms and the apex of the arms was predicted to be flexible, suggesting that DNA-PKcs
may function like pincers, opening and closing around the central channel [9, 46] (Fig. 3).
DNA-PKcs is predicted to contain multiple intrinsically disordered regions, suggesting it has
a high degree of flexibility [47]. Indeed, this conformational flexibility may account for
subtle differences between the cryo-EM and low resolution X-ray structures, particularly at
the base of DNA-PKcs. Interestingly, a recent study using cryo-EM suggests that dsDNA
binds to the flexible region at the base of DNA-PKcs rather than directly in the large central
cavity as suggested earlier [47]. Thus, further work is required to precisely localize the DNA
binding regions within DNA-PKcs. Conformational flexibility is a theme conserved among
other DNA damage response proteins, as RAD50 opens and closes in an ATP-dependent
manner that may be somewhat analogous to DNA-PKcs [48].
The concave surface of the HEAT repeats of DNA-PKcs revealed in the recent X-ray
structure [46] is reminiscent of the structure of PR65, the A subunit of protein phosphatase
2A (PP2A), which is composed entirely of HEAT repeats [49] that act like a molecular
spring to transmit forces between the catalytic and regulatory subunits of PP2A [50]. It is
therefore interesting to speculate that the HEAT repeats in DNA-PKcs and other members of
the PIKK family may function in a similar manner.
As discussed elsewhere, DNA-PKcs function is highly regulated by phosphorylation [1, 9,
51], and over 40 phosphorylation sites have been reported in vitro and/or in vivo [9]. The
solution SAXS structure of autophosphorylated DNA-PKcs revealed extensive
conformational changes and a substantial increase in the maximum dimension (Dmax) of
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DNA-PKcs [30]. We have interpreted the overall SAXS results as indicating that DNA-
PKcs autophosphorylation, possibly at the flexible regions that we expect contains the
cluster of autophosphorylation sites around threonine 2609 (also called the ABCDE cluster),
induces opening of the arms, thus facilitating dissociation of DNA-PKcs from DNA and Ku
[9] (Fig. 3). However, a more detailed understanding of the regulation of DNA-PKcs
function by phosphorylation awaits a higher resolution structure.
The recent 3.2 Å crystal structure of the FAT, kinase and FAT-C domains of the related
PIKK, mTOR, provides the first glimpse of the catalytic mechanism of the PIKK family of
protein kinases [52]. Like the N-terminal domain of DNA-PKcs, the FAT domain of mTOR
is composed of multiple α-helices that form a C-shaped solenoid. Importantly, both the FAT
domain and the FAT-C domain of mTOR are integrally linked to the catalytic domain,
suggesting that they play critical roles in regulating catalytic activity. The kinase domain of
mTOR adopts the two-lobed structure typical of the eukaryotic protein kinase family, as
exemplified by the cAMP-dependent protein kinases and phosphatidyl inositol 3 kinase
p110 catalytic subunit itself [53, 54], suggesting that the PIKKs share a similar catalytic
mechanism to other serine/threonine and lipid kinases. Intriguingly, DNA-PKcs was shown
to contain a putative FKBP12-rapamycin-binding (FRB) domain [52] raising the possibility
that DNA-PKcs could be regulated by rapamycin and/or mTOR inhibitors, many of which
are in clinical trials [55].
The region of DNA-PKcs that interacts with Ku was originally mapped to the C-terminal
~1000 amino acids [56] and residues 4043–4090 have been suggested to act as a PIKK
regulatory domain (PRD) similar to the ATR region required for interaction with ATRIP
[57], however, the precise functional interface between DNA-PKcs and Ku within the DNA-
PK complex remains under investigation.
4. Artemis
Artemis is an endonuclease that plays an essential role in processing DNA hairpins formed
during V(D)J recombination, and acts in the repair of a subset of DNA DSBs by NHEJ that
have “complex” ends and require further end-processing [58]. Artemis has an N-terminal
nuclease domain that belongs to the metallo-β-lactamase and β-CASP families [59] and a C-
terminal regulatory domain that is highly phosphorylated in vivo and predicted to be
unstructured [60–62] (Fig. 4). Artemis interacts with DNA-PKcs [63] and LigIV [64]
through motifs contained in the C-terminal region. Residues 399–404 of Artemis, which are
adjacent to the nuclease domain, interact with DNA-PKcs [65] although the corresponding
interaction region in DNA-PKcs is not known. Recently, Artemis residues 485–495 were
shown to interact with LigIV, with this interaction being essential for V(D)J recombination
[64, 66]. Two groups independently solved crystal structures of this motif in complex with
an open conformation of LigIV [67], or with the LigIV-DNA binding domain (DBD) only
[66]. These structures show that the Artemis motif forms a three-helix bundle with the first
two helices of the LigIV DBD (Fig. 4B). Artemis Trp489 and Phe493 residues bind to a
hydrophobic pocket in LigIV to anchor the interaction (Fig. 4C).
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The structure of the Artemis nuclease domain has remained elusive. Fortunately, crystal
structures of related family members have recently been solved, and these provide
interesting insights relevant to the structure and function of Artemis. Structures of the inter-
strand crosslink repair nuclease SNM1A and Apollo (SNM1B), which share sequence
identity of ~30% to each other and 26% to Artemis, are deposited in the protein databank
(PDB IDs 4B87 and 3ZDK respectively), although details of these structures are
unpublished. The SNM1A and Apollo nucleases superimpose well with each other (root
mean square deviation [RMSD] = 2.2 Å over Cα residues), and the pre-mRNA-3′-end-
processing endonuclease CPSF-73 (RMSD ~3 Å) [68] which shares <20% sequence identity
with SNM1A/Apollo/Artemis.
These structures reveal that the nuclease separates into metallo-β-lactamase and β-CASP
subdomains, with a surprising domain swap where the C-terminal region of the nuclease,
which is annotated as being part of β-CASP subdomain based on sequence, folds with the
metallo-β-lactamase subdomain, capping a beta sheet formed in this region (Fig. 4B).
Interestingly, this domain swap positions a conserved histidine (H319 in Artemis), which
has been proposed to be catalytically important for CSPF-73 [68] into the active site. A
histidine in the Mre11 nuclease acts in opening the dsDNA for access to the active site that
is capped and restricted in access analogously to the Artemis family [69]. One intriguing
possibility for how Artemis activity is regulated is that when DNA-PKcs binds to and/or
phosphorylates the Artemis C-terminal domain, this may be transmitted to the domain swap
region, which is only 15 residues away from the DNA-PKcs interaction motif, to alter the
conformation of key catalytic residues in the active site. For the Mre11-Rad50 end-
processing complex, ATP binding and hydrolysis by Rad50 drives the conformational
change [12].
In the active sites, one zinc ion is seen for SNM1A, with two zinc ions and one sulfate ion
seen for Apollo and CSPF-73. The sulfate has been postulated to mimic the scissile
phosphate, and a mechanism proposed for how CSPF-73 cleaves nucleic acid [68]. The
metal ions are found in a protein cleft that is accessible from a very electropositive face of
the enzyme (Fig. 4B/C). The reverse side of the protein is electronegative, thus it is likely
that DNA substrates bind across the electropositive face of these proteins with the scissile
phosphate entering the active site through the cleft. Interestingly, these enzymes all show
distinct substrate preferences. While CSPF-73 binds to and endonucleolytically cleaves 3′-
ends of mRNA [68]. SNM1A, Apollo and Artemis all show specificity for DNA. SNM1A
and Apollo both have exonuclease activity and can act on ss and dsDNA, with SNM1A
showing a preference for ssDNA and processivity on long DNA substrates not seen for
Apollo [70]. In contrast, Artemis is an endonuclease that cuts in a structure-specific manner
with a preference for hairpins [63, 71] which resembles Mre11 specificity [72]. It will be
interesting to understand how these enzymes bind their nucleic acid substrates, and what
structural features define substrate preferences; however this knowledge awaits
determination of co-complex structures and further biochemical analyses. Currently,
comparative analyses of the DNA-PK and MRN systems may provide insights for
experimental design and interpretation.
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5. The XLF-XRCC4-DNA Ligase IV complex
XRCC4 is a critical NHEJ scaffolding protein. It can interact with itself to form multimeric
complexes, as well as with LigIV, XLF, PNKP, APTX, APLF, Ku and DNA (see [1, 6, 73]).
Examination of full-length XRCC4 and its complexes with LigIV tandem BRCT domains
and XLF in solution by SAXS revealed XRCC4 forms tetramers via a head-to-head interface
supported by the XRCC4 C-terminal region which folds back on itself [74]. Combined
crystallography and SAXS shows that the head domain of XRCC4 forms a hydrophobic
pocket for specific interaction with the head domain of XLF via L115 [75]. The resulting
dimers of XRCC4 and XLF interact to form long, super-helical filaments suitable to bridge
DSB ends for ligation (Figure 6A) [73, 75]. These structures suggest how human XLF and
XRCC4 interact to bind DNA and help explain the mechanistic consequences of patient
mutations [75].
LigIV is composed of N-terminal DNA binding and catalytic domains connected to a C-
terminal tandem BRCT domain separated by a short linker [76] that interacts directly with
the coiled-coil stalk domain of XRCC4 [77, 78]. The BRCT domains of many DNA damage
response proteins bind phospho-proteins [79], however, no phosphoprotein binding partners
have been identified for the tandem BRCT domains of LigIV. Recently, the LigIV BRCT
domains were shown to interact directly with poly ADP ribose polymerase (PAR), the
product of DNA damage activated poly ADP ribose polymerase (PARP) [80]. Moreover,
PAR was responsible for the rapid recruitment of LigIV to sites of DNA damage in vivo
[80], providing a novel mechanism for the recruitment of the XRCC4-LigIV complex to
DSBs. Other PAR binding motifs include the FHA domains of PNKP, and Aprataxin
(APTX) and the FHA-BRCT domain of NBS1, indicating that this mode of recruitment is
common to other DNA damage response proteins.
The recently solved structure of LigIV (residues 1–609) [67] revealed three catalytic
domains (the DNA-binding domain [DBD]; the nucleotidyltransferase domain [Ntase or
NTD], and an OB-fold domain [OBD]) with similarities to those of human DNA ligases I
[81] and III [82]. The LigIV structure is in a relatively open conformation, and we speculate
that the DBD-Ntase-OBD domains are flexible relative to each other, as shown in the
solution X-ray scattering studies of LigI [83] and LigIII [82] in the absence of DNA. In LigI
and III, DNA binding leads to encircling of DNA by the DBD-Ntase-OBD domains, and a
similar arrangement is expected for LigIV.
The flexible linker region between the catalytic core of LigIV and the tandem BRCT domain
is predicted to provide LigIV with considerable range of motion [84]. Although the cryo-EM
structure of XRCC4-LigIV positions the catalytic domain of LigIV near the XRCC4 head
domain [85], our solution X-ray scattering studies of the XRCC4-LigIV complex suggest
flexibility of the catalytic region such that the catalytic domains are in proximity to the
BRCT domain (Figure 5). Together with advanced ensemble modeling, solution scattering
also suggests internal conformational disorder between the individual DBD-Ntase-OBD
domains (Figure 5). Similar conclusions have been postulated from the solution studies of
LigIV in complex with truncated and modified XRCC4ΔCTD;CtoA, where the XRCC4 C-
terminal domain (residues 214–334) is omitted and all cysteines are mutated to alanines
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[86]. Together, these studies suggest that the LigIV catalytic domain adopts dynamic
conformations capable of reaching towards DNA substrates (Figure 5B).
6. Towards a structural and mechanistic understanding of NHEJ multi-
protein-DNA complexes
As discussed above, considerable progress has been made towards determining the
structures of individual NHEJ components and their subdomains. The next challenge is to
elucidate structures of multi protein complexes assembled together on their target, dsDNA
ends, to link complexes and conformations to biology. To deal with the size and
conformational plasticity of these multi-component complexes, approaches such as small
angle x-ray scattering (SAXS) that can characterize the assembly, morphology and the
conformational states [87–89] are likely to be particularly informative. With new methods,
SAXS can comprehensively define protein and DNA conformational states in solution by
objective quantitative measurements, as seen for the mismatch repair ATPase complexes
with DNA [90, 91]. Such comprehensive measurements may be needed to fully understand
NHEJ pathway interactions.
What should we look for to gain a mechanistic and predictive knowledge of NHEJ biology
at the molecular level? Discoveries made from the structural biochemistry of other DNA
repair pathways, such as DNA base excision repair, suggest that protein complexes and
DNA distortions can create platforms for pathway progression and coordination [92–94].
Structures of DNA repair complexes with substrate and product DNA also reveal principles
of negative design that suggest how cells avoid reactions that would cause a loss of genetic
integrity, as seen for the structure-specific nuclease FEN1 [95]. Consideration of the key
importance of coordination of DSB repair steps while maintaining protection of DNA ends
suggests that NHEJ will employ both protein and DNA conformational controls by analogy
with other repair machinery. As discussed in Section 5, recent results have revealed that
NHEJ components form remarkable scaffolding architectures at DSBs, with important roles
for XRCC4 and XLF in this process. The implications of these scaffolds in promoting NHEJ
are vast, thus an important unanswered question in the field is whether such scaffolds do
indeed form in vivo (discussed in [73]).
Given that human cells contain more XRCC4 than LigIV [96], it seems unlikely that each
subunit of XRCC4 in the filament contains a bound LigIV molecule. XRCC4 filaments may
represent a transient storage form that dissociates into dimers upon interaction with the
LigIV-BRCT domain. Indeed, the binding constant for XRCC4 tetramerization is weaker
(KD 22 μM) than that of XRCC4 binding to the LigIV·BRCT domain (estimated KD ~1 nM)
[97] and is reversible. Thus, the interaction of XRCC4 with LigIV will be dominant over
XRCC4 oligomerization and shift the formation of filaments towards the dimeric form [97].
The BRCT domain probably promotes dissociation of XRCC4 filaments by the
displacement of the XRCC4 C-terminus from the head region, which destabilizes the head-
to-head interface [74]. We propose that LigIV may only be present at the ends of the
filaments, where it can directly carry out ligation (Figure 6B). The LigIV tandem BRCT
domain disrupted the large protein-DNA networks observed for XLF-XRCC4-DNA and
disrupted DNA end-bridging by XLF-XRCC4 [98, 99] or XRCC4 [74] in vitro. Thus, we
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hypothesize that XRCC4 homodimers directly involved in end joining might be complexed
to LigIV (Figure 6B), while XRCC4 molecules involved in alignment of DNA ends by
XLF-XRCC4 filaments may be free of LigIV (Figure 6A). This would provide a mechanism
for forming the XRCC4-LigIV complex only at the ends of filaments in the proximity of Ku,
and support a model in which LigIV is not present within the filaments (Figure 6B).
The flexible XRCC4 scaffolding also interacts with PNKP [100] and the related proteins
APLF [101] and APTX [102] providing possible mechanisms to recruit proteins with DNA-
end processing activities to DSBs. PNKP is a 3′-DNA phosphatase, 5′-DNA kinase that
directly removes non-ligatable groups from DNA termini and replaces them with ligatable
5′-phosphates and 3′-hydroxyl groups [103]. The X-ray structure of PNKP reveals an N-
terminal fork-head associated (FHA) domain attached by a flexible linker to the catalytic
phosphatase-kinase domains [104, 105]. The flexible PNKP linker is phosphorylated by
ATM after DNA damage, regulating PNKP function [106, 107]. The PNKP-FHA domain
interacts with CK2-phosphorylated XRCC4 (Figure 6B), through phosphorylated T233
[100], a site in the CTR that is constitutively phosphorylated in vivo [96]. Thus, it has long
been thought that PNKP is recruited to DSBs through its interaction with XRCC4. However,
the FHA domain of PNKP also interacts with PAR and this interaction facilitates the rapid
recruitment of PNKP to sites of DNA damage in vivo [80]. Mechanisms that regulate
binding of phospho-XRCC4 and PAR to the PNKP FHA domain remain to be determined.
Like PNKP, APLF also contains an N-terminal FHA domain that interacts directly with
T233-phosphorylated XRCC4 [108, 109]. Indeed, APLF has emerged as an important
scaffolding protein in NHEJ, interacting with Ku80 as well as XRCC4 and stimulating
NHEJ by enhancing ligation [39, 40, 110]. APLF has also been reported to have exonuclease
activity [101, 111], thus may contribute to processing of DNA termini prior to ligation.
APLF also interacts with PAR, but via its C-terminal PBZ domains [112, 113] rather than its
FHA domain [80], providing a mechanism for its recruitment to chromatin in vivo. APLF
also interacts with histones, and can act as a histone chaperone [114], revealing additional
roles in the DNA damage response. Aprataxin (APTX), which is mutated in ataxia with
oculomotor apraxia 1 (AOA1), removes AMP, formed from abortive ligation reactions, from
DNA termini [102, 115, 116]. Like APLF and PNKP, APTX also interacts with T233-
phosphorylated XRCC4 suggesting roles in DSB repair [102], however, to date, no defects
in DSB repair have been reported in APTX defective cells (discussed in [117]).
The effects of CK2 mediated phosphorylation of XRCC4 on filament structure and how the
interaction of phosphorylated XRCC4 with these various FHA domain-containing proteins
affects filament assembly and dynamics are important questions that need to be addressed.
However, the flexible attachment of the FHA domain to the PNKP catalytic segment,
elucidated by SAXS [105], suggests that PNKP is capable of reaching distal DNA substrates
that are bound by Ku, as proposed for LigIV (Figure 6B). Like LigIV, PNKP, APLF and
APTX carry out their enzymatic functions at DNA ends, therefore, as discussed for LigIV
and PNKP, the flexible scaffold-like arrangement of BRCT and FHA domains may provide
mechanisms to control the access of these enzymes to DSB ends rather than place them
throughout the filaments. The ability of the FHA and BRCT domains of these enzymes to
interact with PAR may also contribute to their localization to DSB ends [80, 112].
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The Ku heterodimer plays a critical role in recruiting multiple NHEJ factors to DSBs [118].
Both XRCC4 and XLF interact with Ku [37, 41, 119, 120] (Figure 6A), and Ku is required
to recruit XRCC4 and XLF to sites of laser-induced DNA damage in vivo [37]. Similarly,
Ku enhances recruitment of XRCC4-LigIV and XLF to DNA in vitro [37, 120].
Surprisingly, XRCC4 was not required to recruit XLF to sites of damage, although it did
help to stabilize/retain XLF at DSBs [37]. Understanding how filaments coordinate with Ku
will therefore be important to understanding their broader functions. As a first step towards
this goal, we determined the overall arrangement of the Ku-DNA-XLF-XRCC4 assembly in
solution using SAXS [75]. Our results suggest that the Ku-DNA complex is positioned on
one side of the XLF-XRCC4 assembly (Figure 6A), providing a possible mechanistic basis
for the Ku-DNA dependent recruitment of the XLF-XRCC4 complex to DSBs in vivo [37].
However, whether Ku binds to DNA ends then translocates inwards allowing the filaments
to form on the free end of the DNA (i.e. proximal to the break), or remains bound to the
DNA termini, allowing filaments to form internal to DNA-bound Ku (i.e. distal to the break)
(Figure 6A), remains to be determined.
Currently we know Ku recruits DNA-PKcs to DNA ends [16, 19], so the location of Ku
relative to the filaments is critical for understanding how DNA-PKcs accesses DNA ends
and functions at DSBs. Upon recruitment, DNA-PKcs undergoes autophosphorylation-
dependent conformational changes (Figure 3B) that regulate its interaction with DNA ends
[9, 30, 121]. The timing of DNA-PKcs recruitment and release, how it is coordinated with
filament formation, and how it might regulate the function of the filaments are all unknown
and will be exciting to decipher. Interestingly, both DNA-PKcs and XLF appear to protect
DNA ends from resection [51, 122–125]. Thus, for NHEJ it is possible that the XRCC4-
XLF filaments do not form until DNA-PKcs has been released and, at this point, the
filaments function to restrict DNA end resection. This would be consistent with the
observation that XLF promotes retention of 3′ overhangs in vitro [126] and that end
resection during V(D)J recombination seems to be restricted by XLF [122, 124, 127, 128].
For MRE11-RAD50, the complex evidently moves away from the DNA ends to make a nick
internal to the DSB that allows resection toward and away from the break [129]. It will be
interesting to see how Ku and XRCC4-XLF protects ends but also allow access for repair
while somehow competing with and regulating Mre11-Rad50 initiation of excision for
homologous recombination. An intriguing possibility that merits more attention is that direct
interactions may provide functional regulation of pathway choice for DSB repair, such as
the interaction between Ku70 and Mre11 proposed from two-hybrid and other data [130].
However we have not seen this interaction in pull-down experiments. Another area of
interest with be the licensing of NHEJ versus HR pathways, which appears to be controlled
in part by the MRE11 nuclease, as well are regulation of MRE11 nuclease end processing
and end protection at stalled forks [131, 132]. One key lesson so far that is underscored by
both the MRN complex [12, 133] and the complexes of Ku-DNA-XLF-XRCC4 is that both
major DSB repair machines employ flexing scaffolds to allow functional activities,
regulation and protection of DSB ends. In this context, the DNA-PKcs and ATM kinases,
composed of multiple HEAT repeats, appear suitable to act as springs that can store
conformational energy, be regulated by post-translational modifications and apply forces to
regulate the flexible scaffold complexes. As we approach answers to questions about the
Williams et al. Page 10






















mechanisms regulating DSB repair, the structures of components and complexes are
providing useful information that will be complemented by a growing understanding of
dynamic complexes including their overall super assembly architecture and conformational
transitions.
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Figure 1. A model for non-homologous end joining
NHEJ is proposed to occur in three stages, detection, and tethering, processing and, finally
ligation. Central to NHE is recognition of the DSB by the Ku70/80 heterodimer. Ku
interacts with multiple NHEJ proteins including DNA-PKcs, the Werner Syndrome helicase
(WRN), DNA polymerases mu and lambda, APLF and XLF, contributing to their
recruitment to DSBs. The catalytic activity of Ku is shown by the red arrows. XLF, LigIV,
APLF, PNKP and APTX interact with XRCC4. Artemis interacts with DNA-PKcs and with
LigIV. Together, these protein-protein interactions stabilize the dynamic NHEJ complex at
DSBs. DNA-PK and ATM-dependent phosphorylation sites are indicated in blue and red,
respectively. DNA-PKcs autophosphorylation regulates its association with the Ku-DNA
complex, end processing and DSB pathway choice (dashed red line). See text for details.
Figure adapted from [6].
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Figure 2. The Ku70/80 heterodimer
Schematics of Ku70 (upper) and Ku80 (lower) showing regions of interaction with XLF,
APLF and DNA-PKcs. The N-terminal region of Ku70 (amino acids 1–33) is disordered and
contains 12 highly acidic amino acids. Ku70 contains N-terminal von Willebrand domain
(vWA) (amino acids 35–249), a core domain (amino acids 266–529) and a C-terminal SAP
domain (amino acids 561–609), which is linked to the core domain via a disordered linker
region (amino acids 536–560). The SAP domain has been proposed to function in DNA
binding and chromatin organization. Ku80, like Ku70, shows similar domain organization
with a vWA domain (amino acids 7–237), a core domain (amino acids 244–543) and a
unique C-terminal region (amino acids 544–732). Amino acids 544–594 are predicted to be
disordered and are followed by a globular region (amino acids 595–704) followed by
another disordered region (amino acids 705–732). The Ku80CTR region has been proposed
to be required for the recruitment of DNA-PKcs. See text for details.
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A. Schematic of DNA-PKcs showing putative domains and in vivo phosphorylation sites
The N-terminal region of DNA-PKcs, extending from residues 1–3022 contains multiple
HEAT repeats and other α-helical regions. A leucine rich region (LRR) spans residues
1503–1602 and has been proposed to be involved in DNA binding. The FAT domain
encompasses residues 3023–3470 and is followed by PI3K-like kinase catalytic region
(residues 3719–4015). The FATC domain spans residues 4097–4128. A PIKK regulatory
domain (PRD) has been proposed between the kinase and FATC domains [57]. Well-
characterized in vivo phosphorylation sites that function in NHEJ (S2056, T2609 and
T3950) are indicated in red. See text for details.
B. Structure of non-phosphorylated and autophosphorylated DNAPKcs highlighting the
autophosphorylation-induced conformational switch. Left: X-ray crystal structure of DNA-
PKcs in complex with the Ku80CTR at 6.6 Å from (PDB ID 3KGV) showing the N-
terminal HEAT/α-helical domains or arms (green), the FAT and FATC domains (magenta),
and the kinase domain (yellow). A putative DNA binding domain (DBD) within the central
cavity is shown in blue and the forehead in light green. The regions where the HEAT
repeat/α-helical (green) arms abut the FAT/kinase/FATC domains (magenta) are predicted
to exhibit conformational flexibility [46]. Phosphorylation within or close to this flexible
region may induce conformational changes that regulate the interaction of DNA-PKcs with
DNA (see [9] and text for details); Overlay of the DNA-PKcs crystal structure on the
average SAXS envelope revealed hollow regions between the arms and bulky kinase region
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[30]. Right: Average SAXS envelopes for autophosphorylated DNA-PKcs overlaid with the
X-ray crystal structure indicate the main conformational changes in the arm regions that
open up the gap at the base [30].
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Figure 4. Structural insights of Artemis
A. Schematic of the domain structure of Artemis showing DNA-PKcs and LigIV interacting
regions, C-terminal phosphorylation sites, and domain similarities to SNM1A, SNM1B/
Apollo and CPSF-73.
B. Structure of the Artemis-LigIV interaction interface (PDB 3W1G). Artemis residues 485–
495 (yellow) complete a 3-helix bundle with the first two helices of LigIV (green). The
DNA LigIV surface reveals a hydrophobic pocket into which Artemis residues Trp489 and
Phe493 insert.
C. The SNM1B/Apollo (PDB 3ZDK) structure as a model for Artemis. (Left) The structure
of SNM1B/Apollo reveals the overall fold of the nuclease domain, which is conserved with
Artemis. The β-CASP (orange) and metallo-β-lactamase (blue) subdomains form two
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distinct lobes, with a domain swap (cyan) from the C-terminal region of the nuclease domain
capping the metallo-β-lactamase subdomain. Zn and sulfate ions bound in the active site are
shown as spheres, with neighboring residues within 4 Å shown as sticks. (Middle and right)
Electrostatic surface of the two faces of SNM1B/Apollo reveal an electropositive surface
(middle) that is likely to bind DNA.
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Figure 5. Flexibility of XRCC4-LigIV in solution
A. Comparison of experimental data and calculated scattering profiles for human XRCC4-
LigIV. Experimental data are represented by the black line. Red and green lines represent
the theoretical scattering curves of the single best-fit conformation (red), and the ensemble
model determined by BILBOMD – MES [134]. Residuals calculated as I(q)experimental/
I(q)model are shown below the scattering curves. The single best model (not shown) fits the
data with χ=2.0; a MES model with both open (52%) and closed (48%) conformations
significantly improved the fit (χ=1.1) and indicated flexibly tethered LigIV.
B. The Ensemble model of XRCC4-LigIV is shown. The sample had been prepared by size
exclusion chromatography immediately prior to SAXS data collection with a final protein
concentration of approximately 1.0 mg/mL. SAXS data were collected and processed at the
Advanced Light Source Beamline 12.3.1 SIBYLS, Lawrence Berkeley National Laboratory
as described [89].
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Figure 6. Towards a structure of NHEJ multi-protein-DNA complexes
A. Left: Atomistic model of full length Ku (red surface) bound to DNA (green) indicating
the extended and flexible Ku80-CTR domain [30] reported to recruit DNA-PKcs to the DSB
[31]. Superimposition of the crystal structure of XLF1–224 -XRCC41–140 [75] and solution
atomistic model of full length XLF (magenta) / full length XRCC4 (blue) [74, 75] was used
to build a hypothetical assembly of Ku-XLF-XRCC4. The XLF CTR region is required for
recruitment of XLF to Ku at the DSB, stabilizing the interaction with XRCC4 [38]. Right:
The initial Ku-XLF-XRCC4 complex may initiate XLF-XRCC4 filament formation [30, 75,
135, 136] and create an extended grooved scaffold to stabilize DSBs [75].
B. Left: Phosphorylation of XRCC4 promotes a high affinity interaction with the FHA
domain of PNKP (orange). The atomistic model of flexibly tethered PNKP was built based
on the PNKP crystal structure [104], SAXS models of PNKP [105] and full length XRCC4
(blue) [74]. The model shows a far-reaching enzyme in the process of interacting with a
DSB.
Right: An atomistic model of XRCC4-LigIV was built based on the known crystal structures
of XRCC4 in complex with the LigIV tandem BRCT domain [77, 78], a SAXS model of full
length XRCC4 [74], the crystal structure of DNA Ligase III [82] and the assumption that
LigIV is flexibly attached to XRCC4 [86]. The model shows the far-reaching LigIV
catalytic core, composed of DBD, NTase and OBD, in the process of DSB ligation.
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